TA
ARRY

Townsend & Associates’s Array Biopharma Inc ARRY Stock Holding History

Townsend & Associates’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-555
Closed -$8K – 158
2018
Q3 		$8K Hold
555
– – 0.01% 137
2018
Q2 		$9K Hold
555
– – 0.01% 133
2018
Q1 		$9K Buy
+555
New +$8.89K 0.01% 132

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Townsend & Associates's ARRY Position: Q4 2018 in Review

Townsend & Associates sold out of Array Biopharma Inc (ARRY) in Q4 2018, closing a stake of 555 shares — an estimated $8K sold.

Townsend & Associates first reported a position in ARRY in Q1 2018 and held it in 3 quarters. The position peaked at $9K in Q2 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

  • Townsend & Associates reported no remaining Array Biopharma Inc position as of Q4 2018 after selling out during the quarter.
  • Townsend & Associates sold 555 Array Biopharma Inc shares in Q4 2018, an estimated $8K.
  • Townsend & Associates first reported a position in Array Biopharma Inc in Q1 2018 and held it in 3 quarters.
  • Townsend & Associates's Array Biopharma Inc position peaked at $9K in Q2 2018.
  • 236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Townsend & Associates's 13F filing for Q4 2018, filed 15 Jan 2019.